Tuesday, November 5, 2024
HomeTagsIgAN

IgAN

Novartis Gets FDA Fast-Track Approval for Fabhalta in IgA Nephropathy

Novartis announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta (iptacopan), a first-in-class complement inhibitor for the reduction...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics